학술논문
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial
Document Type
Article
Author
Source
In Blood 15 June 2008 111(12):5486-5495
Subject
Language
ISSN
0006-4971